6U33 | pdb_00006u33

Structure-based discovery of a novel small-molecule inhibitor of methicillin-resistant S. aureus


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.75 Å
  • R-Value Free: 
    0.217 (Depositor), 0.218 (DCC) 
  • R-Value Work: 
    0.175 (Depositor), 0.175 (DCC) 
  • R-Value Observed: 
    0.177 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6U33

This is version 1.3 of the entry. See complete history

Literature

Structure-based discovery of a small-molecule inhibitor of methicillin-resistantStaphylococcus aureusvirulence.

Liu, J.Kozhaya, L.Torres, V.J.Unutmaz, D.Lu, M.

(2020) J Biological Chem 295: 5944-5959

  • DOI: https://doi.org/10.1074/jbc.RA120.012697
  • Primary Citation Related Structures: 
    6U2S, 6U33, 6U3F, 6U3T, 6U3Y, 6U49, 6U4P

  • PubMed Abstract: 

    The rapid emergence and dissemination of methicillin-resistant Staphylococcus aureus (MRSA) strains poses a major threat to public health. MRSA possesses an arsenal of secreted host-damaging virulence factors that mediate pathogenicity and blunt immune defenses. Panton-Valentine leukocidin (PVL) and α-toxin are exotoxins that create lytic pores in the host cell membrane. They are recognized as being important for the development of invasive MRSA infections and are thus potential targets for antivirulence therapies. Here, we report the high-resolution X-ray crystal structures of both PVL and α-toxin in their soluble, monomeric, and oligomeric membrane-inserted pore states in complex with n -tetradecylphosphocholine (C 14 PC). The structures revealed two evolutionarily conserved phosphatidylcholine-binding mechanisms and their roles in modulating host cell attachment, oligomer assembly, and membrane perforation. Moreover, we demonstrate that the soluble C 14 PC compound protects primary human immune cells in vitro against cytolysis by PVL and α-toxin and hence may serve as the basis for the development of an antivirulence agent for managing MRSA infections.


  • Organizational Affiliation
    • Public Health Research Institute, Department of Microbiology, Biochemistry, and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, New Jersey 07103.

Macromolecule Content 

  • Total Structure Weight: 34.26 kDa 
  • Atom Count: 2,598 
  • Modeled Residue Count: 296 
  • Deposited Residue Count: 301 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Bi-component leukocidin LukED subunit D301Staphylococcus aureusMutation(s): 0 
Gene Names: lukNFlukDBTN44_02870EP54_14125EQ90_10595ER624_13605HMPREF3211_01500NCTC10654_01892NCTC13131_06007RK64_09800
Membrane Entity: Yes 
UniProt
Find proteins for Q2FXB1 (Staphylococcus aureus (strain NCTC 8325 / PS 47))
Explore Q2FXB1 
Go to UniProtKB:  Q2FXB1
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ2FXB1
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NI

Query on NI



Download:Ideal Coordinates CCD File
B [auth A]NICKEL (II) ION
Ni
VEQPNABPJHWNSG-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.75 Å
  • R-Value Free:  0.217 (Depositor), 0.218 (DCC) 
  • R-Value Work:  0.175 (Depositor), 0.175 (DCC) 
  • R-Value Observed: 0.177 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 123.611α = 90
b = 48.732β = 120.85
c = 66.731γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
PDB_EXTRACTdata extraction
HKL-2000data reduction
HKL-2000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)United States--

Revision History  (Full details and data files)

  • Version 1.0: 2020-03-25
    Type: Initial release
  • Version 1.1: 2020-04-01
    Changes: Database references
  • Version 1.2: 2020-05-13
    Changes: Database references
  • Version 1.3: 2023-10-11
    Changes: Data collection, Database references, Derived calculations, Refinement description